🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
The purpose of this study is to determine the relative abuse potential of r...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00671632
Treatments Being Tested
Background and purposes:Chloroquine (CLQ), an antimalarial drug, has a lyso...
Status
Terminated
Location
Instituto Nacional de Cancerologia
Start Date
2011-05
Trial ID
NCT01894633
Treatments Being Tested
This randomized, double-blind, placebo-controlled, single ascending dose st...
Status
Completed
Location
Changi General Hospital; Clinical Trial & Research unit
Start Date
2013-12
Trial ID
NCT02015715
AMD is a leading cause of blindness in individuals over 50 years old, with ...
Status
Recruiting
Location
Washington University
Start Date
2025-12-02
Trial ID
NCT07174687
Treatments Being Tested
The PACIFIC study established the standard of care for immunotherapy consol...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07235306
Treatments Being Tested